Incannex Healthcare (IXHL) Other Operating Expenses (2024)
Incannex Healthcare's (IXHL) quarterly Other Operating Expenses came in at -$1.1 million in Q4 2024.
Analysis
Incannex Healthcare (IXHL) Other Operating Expenses (2024) Analysis & Trends
Incannex Healthcare has disclosed Other Operating Expenses across 1 years of filings, most recently posting -$1.1 million for Q4 2024.
- In Q4 2024, Other Operating Expenses changed N/A year-over-year to -$1.1 million; the TTM figure through Sep 2025 stood at -$1.1 million (changed N/A YoY), while the FY2025 annual figure was -$932000.0, down 13.24% from the prior year.
- Other Operating Expenses came in at -$1.1 million for Q4 2024 at Incannex Healthcare.
- In the past five years, Other Operating Expenses ranged from a high of -$1.1 million in Q4 2024 to a low of -$1.1 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.47 Bn | 624.71 Bn | 17.26 Bn |
| 2 | AbbVie | 439.99 Bn | 433.42 Bn | 12.70 Bn |
| 3 | Merck | 365.45 Bn | 358.31 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.57 Bn | 258.88 Bn | 11.24 Bn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn |
| 10 | Incannex Healthcare | 41.43 Mn | 41.43 Mn | - |